LOTTI, MARCELLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.870
EU - Europa 791
AS - Asia 278
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 6.945
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.864
CN - Cina 236
UA - Ucraina 223
FI - Finlandia 161
DE - Germania 140
SE - Svezia 134
GB - Regno Unito 53
IT - Italia 41
VN - Vietnam 34
FR - Francia 18
IE - Irlanda 8
NL - Olanda 8
CA - Canada 6
IN - India 3
EU - Europa 2
NP - Nepal 2
RO - Romania 2
RU - Federazione Russa 2
SG - Singapore 2
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
CO - Colombia 1
PE - Perù 1
TR - Turchia 1
Totale 6.945
Salva come PNG Salva come JPEG
Città #
Jacksonville 904
Fairfield 866
Woodbridge 623
Houston 403
Chandler 380
Wilmington 377
Seattle 335
Ann Arbor 334
Ashburn 312
Princeton 297
Cambridge 277
Roxbury 122
San Diego 75
Nanjing 64
Boardman 54
Medford 41
Helsinki 36
Dong Ket 34
Beijing 30
Norwalk 24
Guangzhou 23
Hebei 21
Nanchang 20
Shenyang 20
Des Moines 19
Tianjin 11
Kharkiv 10
Dearborn 9
Jiaxing 9
Changsha 8
Dublin 8
London 7
Auburn Hills 6
Kunming 5
Hefei 4
Borås 3
Los Angeles 3
Xian 3
Baotou 2
Chicago 2
Flushing 2
Jinan 2
Kathmandu 2
Milan 2
Ningbo 2
Rome 2
San Mateo 2
Singapore 2
Timisoara 2
Acton 1
Amsterdam 1
Brescia 1
Brisbane 1
Casalecchio Di Reno 1
Chengdu 1
Cienaga de Oro 1
Cittadella 1
Fuzhou 1
Geislingen an der Steige 1
Giardini-Naxos 1
Girifalco 1
Groningen 1
Haikou 1
Hounslow 1
Hull 1
Kilburn 1
La Spezia 1
Lanzhou 1
Leawood 1
Maringá 1
Modena 1
Monmouth Junction 1
Moscow 1
Napoli 1
Ottawa 1
Petronà 1
Prato 1
Redwood City 1
Rockville 1
Santa Cristina Val Gardena 1
Stouffville 1
Taizhou 1
Wuhan 1
Yenibosna 1
Zhengzhou 1
Totale 5.835
Salva come PNG Salva come JPEG
Nome #
Short-term effects of particulate matter: an inflammatory mechanism? 119
Is the acceptable daily intake as presently used an axiom or a dogma? 109
Organophosphorus Compounds 106
Biological monitoring of carcinogens: current status and perspectives. 105
Carbon monoxide pollution is associated with decreased lung function in asthmatic adults 104
Age-related sensitivity of the nervous system to neurotoxic insults 98
Biomonitoring exposures to carcinogens 90
Monitoring occupational exposures to organophosphorus compounds 89
Organophosphate polyneuropathy in chicks. 87
Internal exposure to carcinogenic polycyclic aromatic hydrocarbons and DNA damage 87
Clinical Neurotoxicity of Metals and Neurodegenerative Disorders 86
Chlorpyrifos-induced delayed polyneuropathy 84
Neurotoxic esterase in human nervous tissue. 84
Delayed neurotoxicity caused by chronic feeding of organophosphates requires a high point of inhibition of neurotoxic esterase. 84
Sulfonylfluorides and the promotion of diisopropyl-fluorophosphate neuropathy. 84
Phenylmethanesulfonyl fluoride delays recovery from crush of peripheral nerves in hens. 82
Blood copper in organophosphate-induced delayed polyneuropathy 82
Promotion of organophosphate-induced delayed polyneuropathy by phenylmethanesulfonyl fluoride. 81
Clinical toxicology of anticholinesterase agents in humans 81
Inhibition of lymphocytic neuropathy target esterase predicts the development of organophosphate-induced delayed polyneuropathy. 80
Neurotoxic esterase in peripheral nerve: assay, inhibition and rate of resynthesis. 80
Peripheral nervous system effects and delayed neuropathy 80
Do carbamates cause polyneuropathy? 80
Organophosphate-induced delayed polyneuropathy 80
Central-peripheral delayed neuropathy caused by diisopropyl phosphorofluoridate (DFP): segregation of peripheral nerve and spinal cord effects using biochemical, clinical and morphological criteria. 78
Enzyme studies with human and hen autopsy tissue suggest omethoate does not cause delayed neuropathy in man. 78
Cholinesterases in human toluendiisocyanate exposure. 78
Occupational toxicology of asbestos-related malignancies 78
Neurotoxicity of organophosphorus pesticides: predictions can be based on in vitro studies with hen and human enzymes. 77
Organophosphate polyneuropathy and neuropathy target esterase: studies with methamidophos and its resolved optical isomers. 77
Distribution and some biochemical properties of rat paraoxonase activity. 77
Selective promotion by phenylmethanesulfonyl fluoride of peripheral and spinal cord neuropathies initiated by diisopropyl phosphorofluoridate in the hen. 76
In vivo and in vitro regional differential sensitivity of neuropathy target esterase to Di-n-butyl-2,2 dichlorovinyl phosphate. 76
Toxicologic studies in a fatal overdose of 2,4-D, MCPP, and chlorpyrifos. 75
Pharmacokinetics and blood levels of polychlorinated biphenyls 75
Clinical expression of organophosphate-induced delayed polyneuropathy in rats 74
Neurotoxic effects of workplace exposures 74
Organ distribution of neuropathy target esterase in man 74
Poisoning by organophosphorus insecticides and sensory neuropathy. 73
Treatment of acute organophosphate poisoning. 73
Intra-arterial injection of diisopropylfluorophosphate or phenylmethanesulphonyl fluoride produces unilateral neuropathy or protection,respectively, in hens. 72
Neurotoxic esterase in rooster testis 72
Organophosphate polyneuropathy: pathogenesis and prevention. 72
Meperidine carboxylesterase in mouse and human livers. 72
New approaches in the toxicological evaluation of pesticides. 70
Soluble phenyl-valerate esterases of hen sciatic nerve and the potentiation of organophosphate induced delayed polyneuropathy 70
Promotion of organophosphate induced delayed polyneuropathy by certain esterase inhibitors 69
Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy. 69
Phenyl valerate esterases other than neuropathy target esterase and the promotion of organophosphate polyneuropathy. 68
Clinical Toxicology of Anticholinesterase Agents 66
Cholinesterase inhibition: complexities in interpretation. 65
The pathogenesis of organophosphate delayed polyneuropathy. 65
Treatment of acute organophosphate poisoning: evidence of a direct effect on central nervous system by 2-PAM (pyridine-2-aldoxime methyl chloride). 65
Neuropathy target esterase is not reduced in neural tissues of diabetic rats. 65
Cholinergic symptoms and Gulf War Syndrome. 64
Interaction of methamidophos with hen and human acetylcholinesterase and neuropathy target esterase. 64
Triphenylphosphite neuropathy in hens. 63
Inflammation and short-term cardiopulmonary effects of particulate matter 62
Interazioni metaboliche in tossicologia industriale: l'induzione e l'inibizione enzimatica. 61
Age sensitivity to organophosphate-induced delayed polyneuropathy. Biochemical and toxicological studies in developing chicks. 61
Progressive deficit of retrograde axonal transport is associated with the pathogenesis of di-n-butyl dichlorvos axonopathy 60
Phenylmethanesulfonyl fluoride elicits and intensifies the clinical expression of neuropathy insults. 58
Individual exposure to particulate matter and the short-term arrhythmic and autonomic profiles in patients with myocardial infarction 58
Promotion of organophosphate induced delayed polyneuropathy by certain esterase inhibitors 57
Causes of the gulf war syndrome: Testing hypotheses 56
Peripheral nerve esterases and the promotion of organophosphate-induced neuropathy in hens 52
Delayed neurotoxicity caused by a single massive dose of dichlorovus to adult hens. 51
Occupational exposure to the cotton defoliants DEF and Merphos. A rational approach to monitoring organophosphorus-induced delayed neurotoxicity. 51
The search of the target of promotion: Phenylbenzoate esterase activities in hen peripehral nerve. 50
Exposure to toluene increases the urinary excretion of D-glucaric acid. 49
The relevance of inhibitor-substrate interactions when measuring neuropathy target esterase inhibition 49
Effects of S-ethyl hexahydro-1H-azepine-1-carbothioate (molinate) on di-n-butyl dichlorovinyl phosphate (DBDCVP) neuropathy 48
The relationship between isofenphos cholinergic toxicity and the development of polyneuropathy in hens and humans 48
Effetti dell'erbicida molinate sulla neuropatia da esteri organofosforici: studi biochimici, clinici e morfologici 46
Intossicazioni professionali 46
Toxicity of pesticides 46
Promotion of organophosphate induced delayed polyneuropathy (OPIDP) by certain esterase inhibitors 45
Environment-related cancer: diagnosis and risk assessment 45
Repeated low doses of phosphorothioic acid O-(2-chloro-2,3,3 trifluorocyclobutyl) O-ethyl S-propyl ester (KBR-2822)do not cause neuropathy in hens. 44
Biological monitoring for organophosphate-induced delayed polyneuropathy. 44
Personal Exposure to Particulate Matter Is Associated With Worse Health Perception in Adult Asthma 43
Science and Surmise 42
A risky business 42
Malattie da metalli pesanti. 41
Neuropathy target esterase in human lymphcytes. 40
The mechanism of organophosohate toxicities 40
Neurotoxicology: the Cinderella of Neurosciences 40
Low-level exposures to organophosphorus esters and peripheral nerve function 40
Peripheral nerve esterases and the promotion of organophosphate-induced neuropathy in hens 39
Low level organophosphate exposure causes toxicity (against) 37
La medicina del lavoro accademica 37
The phosphorothioic acid-O-(2-chloro-2,3,3-tri-fluorocyclobutyl)-O-ethyl S-propyl ester promotes organophosphate polyneuropathy without inhibition of neuropathy target esterase. 37
Biomonitoring for organophosphate neurotoxicities 36
Phenyl benzoate esterases and promotion of organophosphate delayed polyneuropaty (OPIDP) 36
Tossicologia dell'amatriciana 34
Chronic effects of exposures to organophosphates 33
Chronic effects of organophosphorus esters 33
Asbestos 32
Chronic effects of exposures to organophosphates 31
Repeated small doses of a neurotoxic organophosphate. Monitoring of neurotoxic esterase in brain and spinal cord. 30
Totale 6.436
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.493
article - articoli 14.244
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.287
Totale 35.024
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019501 0 0 0 0 0 0 0 0 0 0 277 224
2019/20201.678 254 37 38 151 164 173 173 216 156 156 51 109
2020/20211.176 32 114 19 110 20 112 26 137 229 66 173 138
2021/20221.120 43 138 56 67 71 84 10 96 85 50 144 276
2022/2023953 275 33 12 88 206 114 3 63 113 4 34 8
2023/2024140 10 49 29 25 11 0 4 3 4 3 2 0
Totale 6.956